Noticias

China’s NMPA Accepts and Gr...

Shanghai, August 01, 2023 – Luye Pharma Group today announced that...

Patient Enrollment Completed ...

Yantai, July 6, 2023 – Luye Pharma Group announced today that pati...

The NDA for Luye Pharma’s I...

Shanghai, June 6, 2023 – Luye Pharma Group today announced that th...

Luye Pharma and Duopharma Rea...

Kuala Lumpur, Malaysia, April 5th, 2023 - Luye Pharma Group (Luye Ph...

Luye Pharma Announces 2022 Fi...

Yantai, China, March 29, 2023 - Luye Pharma Group (2186.HK) today an...

Luye Pharma Receives Clinical...

Shanghai, February 23, 2023 - Luye Pharma Group today announced that...

Boan Biotech’s Investigatio...

Yantai, February 13, 2023 – Luye Pharma Group today announced that...

Luye Pharma's 3-month Long-ac...

Shanghai, January 30, 2023 — Luye Pharma Group today announced tha...

FDA Approves Luye Pharma’s ...

PRINCETON, N.J., January 15, 2023 – Luye Pharma Group (Luye Pharma...

Boan Biotech Partners with CP...

Yantai, January 10, 2023  Luye Pharma Group today announced that i...

Luye Pharma’s Innovative An...

Hong Kong, China, January 9, 2023 – Luye Pharma Group today announ...